Roivant immune drug significantly outperformed placebo in treating rare skin disease In a small trial, brepocitinib showed promise against cutaneous sarcoidosis By Jason MastFeb. 6, 2026 General Assignment Reporter

https://www.statnews.com/2026/02/06/roivant-immune-drug-significantly-outperformed-placebo-in-treating-rare-skin-disease/